Cover Image

LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma

Objective: To investigate the underlying mechanism of lncRNA TUG1 in pancreatic ductal adenocarcinoma (PDAC). Methods: The expression of TUG1 was defined by qRT-PCR. The apoptotic cells were detected by flow cytometry assay. The cell migration and invasion were measured by scratch assay and Transwel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fan Yang (Author), Xiaofang Li (Author), Lingjuan Zhang (Author), Lina Cheng (Author), Xiuling Li (Author)
Format:	Book
Published:	Elsevier, 2018-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
by: Feng Shao, et al.
Published: (2018)

LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944
by: Ge Gao, et al.
Published: (2023)

lncRNA TUG1 transcript levels and psychological disorders: insights into interplay of glycemic index and glycemic load
by: Niloufar Rasaei, et al.
Published: (2024)

Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats
by: Lei X, et al.
Published: (2018)

An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma
by: Zhijun Xiao, et al.
Published: (2021)

SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling
by: Hao Yu, et al.
Published: (2024)

Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to Induce Autophagy and Inhibit Atherosclerosis
by: You G, et al.
Published: (2020)

LncRNA TUG1 promotes the migration and invasion in type I endometrial carcinoma cells by regulating E-N cadherin switch
by: Qin Chen, et al.
Published: (2022)

Dexmedetomidine hydrochloride inhibits hepatocyte apoptosis and inflammation by activating the lncRNA TUG1/miR-194/SIRT1 signaling pathway
by: Xiao-Xia Gu, et al.
Published: (2021)

The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma
by: Ling-Wei Hii, et al.
Published: (2019)

LncRNA TUG1 positively regulates osteoclast differentiation by targeting v-maf musculoaponeurotic fibrosarcoma oncogene homolog B
by: Ya-jing Du, et al.
Published: (2020)

lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability
by: Junfeng Sun, et al.
Published: (2021)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016)

Risk factors for interstitial lung disease induced by gemcitabine plus albumin-bound paclitaxel therapy in pancreatic ductal adenocarcinoma patients
by: Rikako Ueda, et al.
Published: (2022)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021)

Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma
by: Arash Poursheikhani, et al.
Published: (2020)

lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer
by: Bingyan Liu, et al.
Published: (2018)

LncRNA TUG1 regulates the development of ischemia-reperfusion mediated acute kidney injury through miR-494-3p/E-cadherin axis
by: Li Chen, et al.
Published: (2021)

Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma
by: Keisuke Okuno, et al.
Published: (2022)

Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma
by: Lili Guo, et al.
Published: (2020)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021)

lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
by: Gan Yu, et al.
Published: (2019)

LncRNA FOXD2-AS1 Increased Proliferation and Invasion of Lung Adenocarcinoma via Cell-Cycle Regulation
by: Yuan Y, et al.
Published: (2023)

Ginsenoside Rg3 alleviates septic liver injury by regulating the lncRNA TUG1/miR-200c-3p/SIRT1 axis
by: Pan Wu, et al.
Published: (2021)

Biliary Tract Microbiota Similarities in Pancreatic Ductal Adenocarcinoma
by: Ariel A. Arteta
Published: (2021)

Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
by: Jinlu Liu, et al.
Published: (2023)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
by: Rui Huang, et al.
Published: (2020)

Critical roles of lncRNA-mediated autophagy in urologic malignancies
by: Lifeng Gan, et al.
Published: (2024)

A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
by: Hai-Bo Zhang, et al.
Published: (2023)

Construction of an immunogenic cell death-related LncRNA signature to predict the prognosis of patients with lung adenocarcinoma
by: Shuaishuai Wang, et al.
Published: (2024)

Circulating lncRNA BC030099 Increases in Preeclampsia Patients
by: Yuhong Sun, et al.
Published: (2019)

Construction of an lncRNA model for prognostic prediction of bladder cancer
by: Changlong Shi, et al.
Published: (2022)

Stratification of lncRNA modulation networks in breast cancer
by: Wen-Hsuan Yu, et al.
Published: (2022)

Quantitative indexes of stromal markers expression in the pancreatic ductal adenocarcinoma and chronic pancreatitis
by: V. A. Tumanskiy, et al.
Published: (2015)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
by: Binliang Gan, et al.
Published: (2023)

Discovery of mmu-lncRNA129814/hsa-lncRNA582795 as a Potential Biomarker and Intervention Target for Ischemia Reperfusion Injury-Induced AKI
by: Yang L, et al.
Published: (2024)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
by: Zining Li, et al.
Published: (2022)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
by: Ying Zeng, et al.
Published: (2019)

Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
by: Verena Hofschröer, et al.
Published: (2021)